Vancomycin-Associated Leukocytoclastic Vasculitis

Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pongruangporn, Makhawadee, Ritchie, David J., Lu, Dongsi, Marschall, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336219/
https://www.ncbi.nlm.nih.gov/pubmed/22567469
http://dx.doi.org/10.1155/2011/356370
_version_ 1782230888736620544
author Pongruangporn, Makhawadee
Ritchie, David J.
Lu, Dongsi
Marschall, Jonas
author_facet Pongruangporn, Makhawadee
Ritchie, David J.
Lu, Dongsi
Marschall, Jonas
author_sort Pongruangporn, Makhawadee
collection PubMed
description Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis.
format Online
Article
Text
id pubmed-3336219
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33362192012-05-07 Vancomycin-Associated Leukocytoclastic Vasculitis Pongruangporn, Makhawadee Ritchie, David J. Lu, Dongsi Marschall, Jonas Case Rep Infect Dis Case Report Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis. Hindawi Publishing Corporation 2011 2011-06-30 /pmc/articles/PMC3336219/ /pubmed/22567469 http://dx.doi.org/10.1155/2011/356370 Text en Copyright © 2011 Makhawadee Pongruangporn et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Pongruangporn, Makhawadee
Ritchie, David J.
Lu, Dongsi
Marschall, Jonas
Vancomycin-Associated Leukocytoclastic Vasculitis
title Vancomycin-Associated Leukocytoclastic Vasculitis
title_full Vancomycin-Associated Leukocytoclastic Vasculitis
title_fullStr Vancomycin-Associated Leukocytoclastic Vasculitis
title_full_unstemmed Vancomycin-Associated Leukocytoclastic Vasculitis
title_short Vancomycin-Associated Leukocytoclastic Vasculitis
title_sort vancomycin-associated leukocytoclastic vasculitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336219/
https://www.ncbi.nlm.nih.gov/pubmed/22567469
http://dx.doi.org/10.1155/2011/356370
work_keys_str_mv AT pongruangpornmakhawadee vancomycinassociatedleukocytoclasticvasculitis
AT ritchiedavidj vancomycinassociatedleukocytoclasticvasculitis
AT ludongsi vancomycinassociatedleukocytoclasticvasculitis
AT marschalljonas vancomycinassociatedleukocytoclasticvasculitis

Ejemplares similares